左心室辅助装置中的心室节律失常患者-当前的诊断和治疗考虑
Laura Załucka1, Ewa Świerżyńska2,3, Michał Orczykowski2
1Department of Cardiac Surgery and Transplantology, National Institute of Cardiology, 42 Alpejska Street, 04-628 Warsaw, Poland.
Sensors (Basel, Switzerland)
|February 24, 2024
概括
左心室辅助器件 (LVAD) 可能导致心室节律失常,由于电磁干扰心电图,诊断变得复杂. 本综述涵盖了LVAD心律失常机制,诊断和治疗,以改善患者管理.
科学领域:
- 心脏病学 心脏病学
- 生物医学工程 生物医学工程
- 电子生理学 电子生理学
背景情况:
- 先进的左心室心力衰竭需要机械循环支持.
- 左心室辅助器件 (LVAD) 对于心力衰竭管理至关重要,作为桥梁到移植或目的地治疗.
- 静脉节律失常是LVAD植入物患者的常见并发症.
研究的目的:
- 审查和讨论LVAD患者心室心律失常的机制.
- 探索在LVAD电磁干扰的存在下对心律失常的诊断挑战和方法.
- 概述当前和潜在的治疗策略,以管理这个人群中的心室失常症.
主要方法:
- 关于LVAD和心室节律失常的研究的文献综述.
- 分析由LVAD电磁场引起的心电图 (ECG) 工件.
- 讨论临床案例示例和治疗结果.
主要成果:
- 通过各种机制,LVAD可以诱导或加剧心室节律失常.
- 标准的心电图解释受到LVAD产生的电磁器件的重大挑战.
- 准确的心律失常起源评估需要专门的诊断方法.
结论:
- 静脉节律失常在LVAD患者中构成了重大的临床挑战.
- 需要改进的诊断工具来克服由LVADs引起的ECG解释困难.
- 多方面的治疗策略对于LVAD接受者的有效心律失常管理至关重要.
相关概念视频
Disturbances in Heart Rhythm
956
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
956
Mechanism of Cardiac Arrhythmias
920
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
920
Heart Failure Drugs: Inotropic Agents
588
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
588
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K


